Bromide

Bromide

SCHEMBL7136355

BrCc1ccc2cn[nH]c2c1.[Br-].[H+]

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 4/20 0.55
METAP2 P50579 3/20 0.55
DYRK1A Q13627 2/20 0.55
MAPT P10636 3/20 0.50
KDM4E B2RXH2 1/20 0.50
MEN1 O00255 1/20 0.50
PKM P14618 1/20 0.50
HTT P42858 1/20 0.50
KMT2A Q03164 1/20 0.50
INSR P06213 2/20 0.49
IGF1R P08069 2/20 0.49
FGFR1 P11362 6/20 0.46
FGFR2 P21802 2/20 0.45
FGFR3 P22607 1/20 0.45
CYP3A4 P08684 2/20 0.44
LMNA P02545 1/20 0.44
ALOX15 P16050 1/20 0.44
ALDH1A1 P00352 2/20 0.43
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7472528 0.98 NOS1 (0.56) NOS1METAP2DYRK1AMAPTKDM4E
SCHEMBL7132606 0.96 NOS1 (0.58) NOS1METAP2DYRK1AMAPTKDM4E
SCHEMBL30896276 0.96 NOS1 (0.58) NOS1METAP2DYRK1AMAPTKDM4E
Bromide SCHEMBL7136359 0.95 NOS1 (0.56) NOS1METAP2DYRK1AMAPTKDM4E
Bromide SCHEMBL30477349 0.95 NOS1 (0.56) NOS1METAP2DYRK1AMAPTKDM4E
Bromide SCHEMBL7139986 0.86 NOS1 (0.55) NOS1METAP2DYRK1AMAPTKDM4E
SCHEMBL7510321 0.84 NOS1 (0.56) NOS1METAP2DYRK1AMAPTKDM4E
SCHEMBL6181440 0.82 NOS1 (0.55) NOS1METAP2DYRK1AMAPTKDM4E
SCHEMBL6726541 0.81 NOS1 (0.58) NOS1METAP2DYRK1AMAPTKDM4E
SCHEMBL8669605 0.81 NOS1 (0.57) NOS1METAP2DYRK1AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118317951-A Phthalazine derivatives as pyruvate kinase modulators 西特瑞治疗有限公司 2024-07-09 CN disclosed
WO-2001079195-A9 PYRIDINE AND PYRAZINE DERIVATIVES AS THROMBIN INHIBITORS CORVAS INT INC (US) 2003-10-23 WO disclosed
US-6541467-B1 And at P1 have a six-membered heterocyclic ring having two ring nitrogen ring atoms and the remainder of the ring atoms carbon atoms. CORVAS INTERNATIONAL, INC. 2003-04-01 US disclosed
US-6506761-B1 Compound of the invention are active as inhibitors of Thrombin and are useful in treating disease states in mammals which are characterized by abnormal thrombosis and have the following structure: CORVAS INTERNATIONAL, INC. 2003-01-14 US disclosed
US-6506754-B1 Compounds as anticoagulants CORVAS INTERNATIONAL, INC. 2003-01-14 US disclosed
US-6506760-B1 Compounds of the invention are active as inhibitors of Thrombin and are useful in treating disease states in mammals which are characterized by abnormal thrombosis and have the following structure: CORVAS INTERNATIONAL, INC. 2003-01-14 US disclosed
WO-2001079193-A2 SUBSTITUTED HYDRAZINYL HETEROAROMATIC INHIBITORS OF THROMBIN CORVAS INTERNATIONAL, INC. (US) 2001-10-25 WO disclosed
WO-2001079195-A2 PYRIDINE AND PYRAZINE DERIVATIVES AS THROMBIN INHIBITORS CORVAS INTERNATIONAL, INC. (US) 2001-10-25 WO disclosed
WO-2001079262-A1 PYRAZINONE AND PYRIDINONE DERIVATIVES AS THROMBIN INHIBITORS CORVAS INTERNATIONAL, INC. (US) 2001-10-25 WO disclosed